Genelux Corporation Common Stock (GNLX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $84.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Genelux Corporation Common Stock (GNLX) Stock Forecast
Analysts expect Genelux Corporation Common Stock (GNLX) to earn -$0.82 per share in the fiscal year ending Dec 31, 2026. Of 5 analysts, 5 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 3 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 1.80, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 4 | 80.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$0.82
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$0.75
- EPS consensus, revenue $7.85M
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.82 | -$0.86 to -$0.77 | 6 | N/A | N/A | 6 |
| Dec 31, 2027 | -$0.75 | -$0.92 to -$0.56 | 6 | $7.85M | N/A | 6 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.20 | -$0.23 to -$0.18 | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 3 |
| Fiscal year ending Dec 31, 2027 | 2 | 2 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 is where it was 90 days ago.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.82 | -$0.81 | -$0.82 | -$0.82 | -$0.82 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.75 | -$0.74 | -$0.75 | -$0.76 | -$0.76 | N/A |
Frequently Asked Questions About GNLX
What is the GNLX stock forecast?
Consensus analyst estimates put Genelux Corporation Common Stock's EPS at -$0.82 for the fiscal year ending Dec 31, 2026. The consensus rating from 5 analysts is Buy.
How do analysts rate GNLX stock?
Of 5 analysts covering Genelux Corporation Common Stock, 1 rates it Strong Buy, 4 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from GNLX next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.82, with estimates from -$0.86 to -$0.77 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.75, with estimates from -$0.92 to -$0.56 from 6 analysts.
What revenue do analysts expect from Genelux Corporation Common Stock next year?
For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $7.85M.
How many analysts cover GNLX?
5 analysts rate Genelux Corporation Common Stock stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
GNLX pages: Overview, Earnings, Forecast, Financials, Competitors